Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Travel | 83 | 2024 | 805 | 14.000 |
Why?
|
Travel Medicine | 22 | 2024 | 83 | 4.940 |
Why?
|
Yellow Fever | 12 | 2019 | 54 | 3.930 |
Why?
|
Dengue | 17 | 2024 | 258 | 3.250 |
Why?
|
Yellow Fever Vaccine | 9 | 2019 | 38 | 2.510 |
Why?
|
Chikungunya virus | 6 | 2024 | 56 | 2.350 |
Why?
|
Communicable Diseases | 15 | 2023 | 874 | 2.280 |
Why?
|
Rabies | 6 | 2023 | 56 | 1.940 |
Why?
|
Vaccination | 23 | 2023 | 3437 | 1.510 |
Why?
|
Dengue Virus | 9 | 2024 | 204 | 1.440 |
Why?
|
Antimalarials | 6 | 2020 | 909 | 1.360 |
Why?
|
Medical Tourism | 3 | 2015 | 51 | 1.320 |
Why?
|
Malaria | 12 | 2023 | 1249 | 1.310 |
Why?
|
Communicable Diseases, Emerging | 5 | 2019 | 149 | 1.290 |
Why?
|
Diarrhea | 7 | 2024 | 1320 | 0.980 |
Why?
|
Serologic Tests | 4 | 2020 | 382 | 0.940 |
Why?
|
Buruli Ulcer | 1 | 2024 | 11 | 0.940 |
Why?
|
Sentinel Surveillance | 8 | 2024 | 292 | 0.930 |
Why?
|
Burkholderia pseudomallei | 1 | 2023 | 7 | 0.880 |
Why?
|
Melioidosis | 1 | 2023 | 9 | 0.870 |
Why?
|
Aedes | 2 | 2023 | 101 | 0.870 |
Why?
|
Infectious Disease Medicine | 2 | 2014 | 49 | 0.860 |
Why?
|
Vaccines, Attenuated | 1 | 2024 | 314 | 0.860 |
Why?
|
Alphavirus Infections | 3 | 2012 | 20 | 0.850 |
Why?
|
Internationality | 7 | 2016 | 1008 | 0.840 |
Why?
|
Hepatitis B | 4 | 2016 | 711 | 0.830 |
Why?
|
Bites and Stings | 2 | 2020 | 94 | 0.760 |
Why?
|
Japanese Encephalitis Vaccines | 2 | 2018 | 7 | 0.760 |
Why?
|
Encephalitis, Japanese | 2 | 2018 | 13 | 0.750 |
Why?
|
Viral Vaccines | 3 | 2024 | 596 | 0.750 |
Why?
|
Disease Transmission, Infectious | 3 | 2020 | 560 | 0.730 |
Why?
|
Yellow fever virus | 2 | 2019 | 23 | 0.720 |
Why?
|
Health Systems Plans | 1 | 2020 | 20 | 0.720 |
Why?
|
Hepatitis A | 4 | 2022 | 126 | 0.680 |
Why?
|
Transients and Migrants | 2 | 2023 | 170 | 0.640 |
Why?
|
Zoonoses | 1 | 2020 | 180 | 0.630 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3115 | 0.610 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.600 |
Why?
|
Influenza Vaccines | 2 | 2023 | 781 | 0.590 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 2018 | 39 | 0.590 |
Why?
|
Motion Sickness | 1 | 2018 | 33 | 0.590 |
Why?
|
Dysentery | 1 | 2017 | 14 | 0.580 |
Why?
|
Disease Outbreaks | 6 | 2019 | 1761 | 0.570 |
Why?
|
Oral Ulcer | 1 | 2018 | 96 | 0.560 |
Why?
|
Vaccines | 4 | 2023 | 842 | 0.540 |
Why?
|
Arthritis, Psoriatic | 1 | 2019 | 219 | 0.530 |
Why?
|
Communicable Disease Control | 4 | 2015 | 857 | 0.530 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2016 | 4055 | 0.520 |
Why?
|
Congresses as Topic | 1 | 2020 | 812 | 0.500 |
Why?
|
Malaria, Falciparum | 2 | 2023 | 1077 | 0.500 |
Why?
|
Diagnostic Errors | 2 | 2013 | 1281 | 0.500 |
Why?
|
Milk, Human | 2 | 2010 | 490 | 0.500 |
Why?
|
Influenza, Human | 3 | 2023 | 1541 | 0.490 |
Why?
|
Antibodies, Viral | 6 | 2020 | 3216 | 0.490 |
Why?
|
Humans | 111 | 2024 | 768166 | 0.470 |
Why?
|
General Practice | 1 | 2015 | 101 | 0.460 |
Why?
|
Rabies Vaccines | 3 | 2020 | 29 | 0.460 |
Why?
|
Breast Feeding | 3 | 2017 | 1363 | 0.460 |
Why?
|
Adoption | 2 | 2005 | 97 | 0.460 |
Why?
|
General Practitioners | 1 | 2015 | 103 | 0.460 |
Why?
|
User-Computer Interface | 1 | 2020 | 1407 | 0.460 |
Why?
|
Enterobacteriaceae | 1 | 2015 | 161 | 0.450 |
Why?
|
Enterobacteriaceae Infections | 1 | 2015 | 190 | 0.430 |
Why?
|
beta-Lactamases | 1 | 2015 | 307 | 0.420 |
Why?
|
Rickettsia Infections | 2 | 2009 | 8 | 0.420 |
Why?
|
Cultural Competency | 1 | 2015 | 303 | 0.400 |
Why?
|
Sexually Transmitted Diseases | 2 | 2018 | 668 | 0.400 |
Why?
|
Drug Resistance | 2 | 2016 | 1599 | 0.400 |
Why?
|
Asia | 7 | 2024 | 629 | 0.390 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 2 | 2005 | 249 | 0.390 |
Why?
|
Research | 2 | 2017 | 1979 | 0.360 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2015 | 591 | 0.360 |
Why?
|
Endemic Diseases | 5 | 2016 | 191 | 0.350 |
Why?
|
Dengue Vaccines | 2 | 2024 | 16 | 0.340 |
Why?
|
Epidemics | 1 | 2016 | 517 | 0.340 |
Why?
|
Brazil | 6 | 2019 | 1250 | 0.340 |
Why?
|
Pandemics | 6 | 2023 | 8748 | 0.330 |
Why?
|
Gastrointestinal Diseases | 2 | 2018 | 1206 | 0.330 |
Why?
|
Tick-Borne Diseases | 1 | 2009 | 37 | 0.320 |
Why?
|
Disease Vectors | 4 | 2020 | 61 | 0.320 |
Why?
|
Risk Assessment | 11 | 2021 | 24315 | 0.320 |
Why?
|
Caribbean Region | 4 | 2023 | 193 | 0.320 |
Why?
|
Immunization Schedule | 2 | 2023 | 228 | 0.310 |
Why?
|
Self Report | 2 | 2017 | 3773 | 0.300 |
Why?
|
Americas | 4 | 2020 | 110 | 0.300 |
Why?
|
Post-Exposure Prophylaxis | 4 | 2020 | 113 | 0.300 |
Why?
|
Mass Screening | 4 | 2017 | 5458 | 0.290 |
Why?
|
Patient Preference | 1 | 2015 | 946 | 0.290 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3781 | 0.280 |
Why?
|
Commerce | 3 | 2018 | 612 | 0.270 |
Why?
|
Europe | 4 | 2023 | 3436 | 0.270 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2018 | 2185 | 0.270 |
Why?
|
Language | 1 | 2015 | 1557 | 0.260 |
Why?
|
Universal Precautions | 1 | 2005 | 34 | 0.250 |
Why?
|
Male | 47 | 2024 | 364719 | 0.250 |
Why?
|
China | 3 | 2020 | 2395 | 0.240 |
Why?
|
Thailand | 2 | 2023 | 288 | 0.240 |
Why?
|
Mycobacterium ulcerans | 1 | 2024 | 9 | 0.240 |
Why?
|
Cyclosporiasis | 1 | 2024 | 4 | 0.240 |
Why?
|
North America | 2 | 2019 | 1289 | 0.240 |
Why?
|
Referral and Consultation | 2 | 2014 | 3620 | 0.240 |
Why?
|
Giardiasis | 1 | 2024 | 28 | 0.230 |
Why?
|
Adult | 41 | 2024 | 223646 | 0.230 |
Why?
|
Health Education | 2 | 2014 | 1059 | 0.230 |
Why?
|
Cryptosporidiosis | 1 | 2024 | 52 | 0.230 |
Why?
|
Boston | 9 | 2017 | 9374 | 0.220 |
Why?
|
Antibodies, Neutralizing | 3 | 2024 | 2011 | 0.220 |
Why?
|
Emigration and Immigration | 1 | 2006 | 406 | 0.210 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2010 | 1354 | 0.210 |
Why?
|
Female | 46 | 2024 | 397192 | 0.210 |
Why?
|
South America | 3 | 2024 | 180 | 0.210 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3488 | 0.200 |
Why?
|
Young Adult | 25 | 2024 | 60066 | 0.200 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5367 | 0.200 |
Why?
|
Health Care Costs | 1 | 2015 | 3239 | 0.190 |
Why?
|
France | 1 | 2023 | 497 | 0.190 |
Why?
|
Ochlerotatus | 1 | 2020 | 4 | 0.190 |
Why?
|
Immunization | 3 | 2016 | 1219 | 0.190 |
Why?
|
Encephalitis Virus, California | 1 | 2020 | 9 | 0.180 |
Why?
|
Hepatitis A Vaccines | 2 | 2022 | 26 | 0.180 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2021 | 86 | 0.180 |
Why?
|
Public Health | 1 | 2014 | 2679 | 0.180 |
Why?
|
Latent Tuberculosis | 1 | 2023 | 224 | 0.180 |
Why?
|
Culicidae | 1 | 2020 | 111 | 0.170 |
Why?
|
Middle Aged | 32 | 2024 | 223492 | 0.170 |
Why?
|
Risk | 5 | 2015 | 9613 | 0.170 |
Why?
|
Angola | 1 | 2019 | 18 | 0.170 |
Why?
|
Antidiarrheals | 2 | 2017 | 46 | 0.170 |
Why?
|
Costa Rica | 2 | 2018 | 186 | 0.170 |
Why?
|
India | 3 | 2019 | 2334 | 0.160 |
Why?
|
Hepatitis B Antibodies | 2 | 2013 | 156 | 0.160 |
Why?
|
Seasons | 2 | 2023 | 1524 | 0.160 |
Why?
|
Animals | 14 | 2024 | 169246 | 0.160 |
Why?
|
Meningitis | 1 | 2020 | 219 | 0.160 |
Why?
|
Quarantine | 1 | 2021 | 186 | 0.150 |
Why?
|
Central America | 2 | 2016 | 69 | 0.150 |
Why?
|
Leptospira | 1 | 2018 | 25 | 0.150 |
Why?
|
Sexual Abstinence | 1 | 2018 | 17 | 0.150 |
Why?
|
Fever | 4 | 2019 | 1614 | 0.150 |
Why?
|
Leptospirosis | 1 | 2018 | 45 | 0.150 |
Why?
|
Loperamide | 1 | 2017 | 10 | 0.150 |
Why?
|
Echinococcosis | 1 | 2017 | 32 | 0.140 |
Why?
|
Occupational Medicine | 1 | 2018 | 116 | 0.140 |
Why?
|
Climate Change | 1 | 2023 | 509 | 0.140 |
Why?
|
Certification | 1 | 2020 | 420 | 0.140 |
Why?
|
Encephalitis | 1 | 2020 | 441 | 0.140 |
Why?
|
HIV Infections | 1 | 2023 | 17569 | 0.130 |
Why?
|
Pregnancy | 7 | 2020 | 30256 | 0.130 |
Why?
|
Risk Factors | 10 | 2024 | 74944 | 0.130 |
Why?
|
Hepatitis B virus | 2 | 2013 | 533 | 0.130 |
Why?
|
Immunization, Secondary | 1 | 2018 | 373 | 0.130 |
Why?
|
Antiviral Agents | 2 | 2022 | 3073 | 0.130 |
Why?
|
Azithromycin | 1 | 2017 | 201 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2017 | 246 | 0.130 |
Why?
|
Ciprofloxacin | 1 | 2017 | 313 | 0.120 |
Why?
|
West Indies | 1 | 2014 | 32 | 0.120 |
Why?
|
Arthralgia | 1 | 2019 | 459 | 0.120 |
Why?
|
Africa South of the Sahara | 1 | 2018 | 752 | 0.120 |
Why?
|
Hepatitis B Vaccines | 1 | 2016 | 178 | 0.120 |
Why?
|
Immunization Programs | 1 | 2017 | 267 | 0.120 |
Why?
|
Adolescent | 18 | 2024 | 89169 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 4 | 2023 | 3231 | 0.120 |
Why?
|
Skin Diseases, Parasitic | 1 | 2014 | 13 | 0.120 |
Why?
|
Antibody Formation | 1 | 2018 | 1393 | 0.110 |
Why?
|
Occupational Health | 1 | 2020 | 812 | 0.110 |
Why?
|
United States | 9 | 2023 | 73039 | 0.110 |
Why?
|
Tropical Medicine | 1 | 2014 | 52 | 0.110 |
Why?
|
Aged | 21 | 2024 | 171504 | 0.110 |
Why?
|
Treatment Failure | 1 | 2020 | 2661 | 0.110 |
Why?
|
Topography, Medical | 1 | 2013 | 37 | 0.110 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7477 | 0.110 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2021 | 944 | 0.110 |
Why?
|
Cluster Analysis | 1 | 2020 | 2732 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 2 | 2014 | 1805 | 0.100 |
Why?
|
Consultants | 1 | 2013 | 57 | 0.100 |
Why?
|
Pregnant Women | 1 | 2017 | 576 | 0.100 |
Why?
|
Developing Countries | 2 | 2017 | 2910 | 0.100 |
Why?
|
World Health Organization | 1 | 2018 | 1329 | 0.100 |
Why?
|
Typhoid Fever | 1 | 2014 | 195 | 0.100 |
Why?
|
Child | 12 | 2024 | 80917 | 0.100 |
Why?
|
Massachusetts | 3 | 2020 | 8890 | 0.100 |
Why?
|
Mosquito Control | 1 | 2012 | 110 | 0.100 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2013 | 294 | 0.100 |
Why?
|
Headache | 1 | 2019 | 1263 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1397 | 0.090 |
Why?
|
Population Surveillance | 3 | 2009 | 2596 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1930 | 0.090 |
Why?
|
Frostbite | 1 | 2010 | 24 | 0.090 |
Why?
|
Immunoglobulin M | 2 | 2016 | 1528 | 0.080 |
Why?
|
Child, Preschool | 8 | 2024 | 42669 | 0.080 |
Why?
|
Rickettsia | 1 | 2009 | 11 | 0.080 |
Why?
|
Honduras | 1 | 2009 | 39 | 0.080 |
Why?
|
Family Health | 2 | 2005 | 1255 | 0.080 |
Why?
|
Bacterial Vaccines | 1 | 2011 | 400 | 0.080 |
Why?
|
Altitude Sickness | 1 | 2010 | 93 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2911 | 0.080 |
Why?
|
Meningococcal Infections | 1 | 2008 | 78 | 0.080 |
Why?
|
Italy | 1 | 2010 | 856 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59629 | 0.070 |
Why?
|
Sports | 1 | 2014 | 703 | 0.070 |
Why?
|
Prospective Studies | 5 | 2023 | 54926 | 0.070 |
Why?
|
Students | 1 | 2018 | 1744 | 0.070 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2008 | 136 | 0.070 |
Why?
|
Mefloquine | 1 | 2007 | 55 | 0.070 |
Why?
|
Primaquine | 1 | 2007 | 28 | 0.070 |
Why?
|
Health Priorities | 1 | 2010 | 380 | 0.070 |
Why?
|
Physicians, Primary Care | 1 | 2014 | 624 | 0.070 |
Why?
|
Hepatitis A Antibodies | 1 | 2006 | 19 | 0.070 |
Why?
|
Infant | 6 | 2024 | 36535 | 0.070 |
Why?
|
Virulence | 1 | 2010 | 1297 | 0.070 |
Why?
|
Hepatitis A virus | 1 | 2006 | 16 | 0.070 |
Why?
|
Measles | 1 | 2008 | 180 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2389 | 0.070 |
Why?
|
Prevalence | 4 | 2020 | 15869 | 0.060 |
Why?
|
Incidence | 4 | 2023 | 21538 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2216 | 0.060 |
Why?
|
Counseling | 1 | 2013 | 1554 | 0.060 |
Why?
|
Virus Diseases | 1 | 2011 | 724 | 0.060 |
Why?
|
History, 21st Century | 1 | 2011 | 1573 | 0.060 |
Why?
|
Immunoglobulin G | 2 | 2016 | 4568 | 0.060 |
Why?
|
Seroepidemiologic Studies | 1 | 2006 | 404 | 0.060 |
Why?
|
Cyclospora | 1 | 2024 | 2 | 0.060 |
Why?
|
Giardia lamblia | 1 | 2024 | 23 | 0.060 |
Why?
|
Cryptosporidium | 1 | 2024 | 43 | 0.060 |
Why?
|
Societies, Medical | 2 | 2013 | 3968 | 0.060 |
Why?
|
Medication Adherence | 1 | 2015 | 2187 | 0.060 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 939 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2011 | 1397 | 0.050 |
Why?
|
Antibodies, Bacterial | 1 | 2009 | 1479 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3272 | 0.050 |
Why?
|
Patient Compliance | 1 | 2013 | 2697 | 0.050 |
Why?
|
Accidents, Occupational | 1 | 2004 | 251 | 0.050 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 983 | 0.050 |
Why?
|
Plasmodium | 1 | 2005 | 248 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2010 | 7454 | 0.050 |
Why?
|
Medical Records | 1 | 2006 | 1410 | 0.040 |
Why?
|
Health Behavior | 2 | 2012 | 2650 | 0.040 |
Why?
|
Comorbidity | 1 | 2013 | 10590 | 0.040 |
Why?
|
Laos | 1 | 2018 | 27 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2018 | 117 | 0.040 |
Why?
|
Indonesia | 1 | 2018 | 131 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3814 | 0.040 |
Why?
|
Asia, Southeastern | 1 | 2017 | 115 | 0.040 |
Why?
|
Mice | 1 | 2024 | 82029 | 0.040 |
Why?
|
Consensus | 1 | 2007 | 3212 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2018 | 556 | 0.030 |
Why?
|
Genome, Viral | 1 | 2020 | 674 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2009 | 2517 | 0.030 |
Why?
|
Jet Lag Syndrome | 1 | 2016 | 24 | 0.030 |
Why?
|
Respiratory Tract Infections | 2 | 2018 | 1014 | 0.030 |
Why?
|
Arbovirus Infections | 1 | 2016 | 21 | 0.030 |
Why?
|
Chick Embryo | 1 | 2018 | 975 | 0.030 |
Why?
|
Doxycycline | 1 | 2018 | 349 | 0.030 |
Why?
|
Dogs | 1 | 2020 | 3845 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2023 | 81762 | 0.030 |
Why?
|
Chemoprevention | 1 | 2017 | 327 | 0.030 |
Why?
|
Guillain-Barre Syndrome | 1 | 2016 | 127 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2024 | 26422 | 0.030 |
Why?
|
Spain | 1 | 2016 | 485 | 0.030 |
Why?
|
Tungiasis | 1 | 2014 | 3 | 0.030 |
Why?
|
Larva Migrans | 1 | 2014 | 7 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2010 | 4530 | 0.030 |
Why?
|
Africa | 1 | 2016 | 725 | 0.030 |
Why?
|
Peru | 1 | 2017 | 890 | 0.030 |
Why?
|
Germany | 1 | 2016 | 883 | 0.030 |
Why?
|
Health Promotion | 1 | 2005 | 2210 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2843 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26379 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2021 | 1397 | 0.030 |
Why?
|
Typhoid-Paratyphoid Vaccines | 1 | 2012 | 40 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9495 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2872 | 0.020 |
Why?
|
Malaria, Vivax | 1 | 2014 | 168 | 0.020 |
Why?
|
Friends | 1 | 2012 | 149 | 0.020 |
Why?
|
Abdomen | 1 | 2017 | 1136 | 0.020 |
Why?
|
Portugal | 1 | 2010 | 91 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1741 | 0.020 |
Why?
|
Health Status | 1 | 2003 | 4091 | 0.020 |
Why?
|
Stomatognathic Diseases | 1 | 2010 | 21 | 0.020 |
Why?
|
Mental Disorders | 1 | 2009 | 6874 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2016 | 843 | 0.020 |
Why?
|
Hepatitis, Viral, Human | 1 | 2010 | 141 | 0.020 |
Why?
|
Decision Making | 2 | 2014 | 3953 | 0.020 |
Why?
|
Singapore | 1 | 2009 | 300 | 0.020 |
Why?
|
Needs Assessment | 1 | 2014 | 1141 | 0.020 |
Why?
|
Time Factors | 1 | 2009 | 40218 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2012 | 640 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6340 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 500 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3436 | 0.020 |
Why?
|
Blood | 1 | 2009 | 599 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 14164 | 0.020 |
Why?
|
Health Surveys | 1 | 2016 | 4057 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2010 | 997 | 0.010 |
Why?
|
Irritable Bowel Syndrome | 1 | 2010 | 454 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2010 | 15662 | 0.010 |
Why?
|
Ultrasonography | 1 | 2017 | 6004 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8741 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 2010 | 804 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39348 | 0.010 |
Why?
|
Family | 1 | 2012 | 3209 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3929 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3269 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41754 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10632 | 0.010 |
Why?
|
Concepts
(305)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_